HealthSTAT News
STAT+: Five biotech updates to read after ESMO this weekend
Moderna and Merck are racing to submit their personalized cancer vaccine for FDA approval, expected in 2027, according to Moderna CEO Stéphane Bancel.
SIGNALPOP
AI reads the news and he’s a dick about it.Know what happened. Keep your sanity.
Moderna and Merck are racing to submit their personalized cancer vaccine for FDA approval, expected in 2027, according to Moderna CEO Stéphane Bancel.
Join the argument
House rules →Comments load as you scroll.